Investigational Drug Information for Fluzoparib
✉ Email this page to a colleague
What is the development status for investigational drug Fluzoparib?
Fluzoparib is an investigational drug.
There have been 51 clinical trials for Fluzoparib.
The most recent clinical trial was a Phase 1 trial, which was initiated on July 13th 2020.
The most common disease conditions in clinical trials are Breast Neoplasms, Ovarian Neoplasms, and Carcinoma, Ovarian Epithelial. The leading clinical trial sponsors are Jiangsu HengRui Medicine Co., Ltd., Fudan University, and Atridia Pty Ltd.
There are two US patents protecting this investigational drug and twenty-one international patents.
Summary for Fluzoparib
| US Patents | 2 |
| International Patents | 21 |
| US Patent Applications | 28 |
| WIPO Patent Applications | 34 |
| Japanese Patent Applications | 8 |
| Clinical Trial Progress | Phase 1 (2020-07-13) |
| Vendors | 24 |
Recent Clinical Trials for Fluzoparib
| Title | Sponsor | Phase |
|---|---|---|
| Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer | Fudan University | Phase 3 |
| Brachytherapy (Iodine-125 Seeds) and Fluzoparib Combination Therapy for Advanced Unresectable Soft Tissue Sarcoma | Fujun Zhang | Phase 2 |
| Neoadjuvant Fluzoparib in Germline BRCA-mutated Three-negative Breast Cancer Breast Cancer | Jiangsu HengRui Medicine Co., Ltd. | Phase 2 |
Clinical Trial Summary for Fluzoparib
Top disease conditions for Fluzoparib
Top clinical trial sponsors for Fluzoparib
US Patents for Fluzoparib
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Fluzoparib | ⤷ Try a Trial | Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof | Jiangsu Hansoh Pharmaceutical Co., Ltd. (Lianyungang, Jiangsu, CN) | ⤷ Try a Trial |
| Fluzoparib | ⤷ Try a Trial | Methods of using phthalazinone ketone derivatives | Jiangsu Hansoh Pharmaceutical Co., Ltd. (Lianyungang, Jiangsu, CN) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Fluzoparib
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Fluzoparib | Australia | AU2011288876 | 2030-08-09 | ⤷ Try a Trial |
| Fluzoparib | Brazil | BR112013002220 | 2030-08-09 | ⤷ Try a Trial |
| Fluzoparib | Canada | CA2806324 | 2030-08-09 | ⤷ Try a Trial |
| Fluzoparib | China | CN102372716 | 2030-08-09 | ⤷ Try a Trial |
| Fluzoparib | China | CN102686591 | 2030-08-09 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
